Time in range: a new parameter to evaluate blood glucose control in patients with diabetes

Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease

(2020) Laura Mayeda et al.   BMJ Open Diabetes Research & Care

Translating Glycated Hemoglobin A1c into Time Spent in Glucose Target Range: a Multicenter Study

(2019) Jonathan Petersson et al.   PEDIATRIC DIABETES

Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies

(2019) Karl Kristensen et al.   DIABETOLOGIA

Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes

(2019) Irl B. Hirsch et al.   DIABETES CARE

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

(2019) Tadej Battelino et al.   DIABETES CARE

Associations between HbA 1c and continuous glucose monitoring‐derived glycaemic variables

(2019) I. B. Hirsch et al.   DIABETIC MEDICINE

Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters

(2019) Helen R. Murphy   DIABETOLOGIA

Time in range is associated with carotid intima-media thickness in type 2 diabetes

(2019) Jingyi Lu et al.   Diabetes Technology & Therapeutics

Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels

(2019) Suresh Rama Chandran et al.   Diabetes Technology & Therapeutics

Differences for Percentage Times in Glycemic Range Between Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring in Adults with Type 1 Diabetes: Analysis of the REPLACE-BG Dataset

(2019) Parizad Avari et al.   Diabetes Technology & Therapeutics

Metrics to Evaluate Quality of Glycemic Control: Comparison of Time in Target, Hypoglycemic, and Hyperglycemic Ranges with “Risk Indices”

(2018) David Rodbard   Diabetes Technology & Therapeutics

Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes

(2018) Jingyi Lu et al.   DIABETES CARE

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring

(2018) Richard M. Bergenstal et al.   DIABETES CARE

Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials

(2018) Roy W. Beck et al.   DIABETES CARE

Comment on Bergenstal et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018;41:2275–2280

(2018) Kristen M. Pluchino et al.   DIABETES CARE

The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes

(2018) Robert A. Vigersky et al.   Diabetes Technology & Therapeutics

Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial

(2017) Denice S Feig et al.   LANCET

Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes: Table 1

(2016)   DIABETES CARE

Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring

(2016) Ahmed H. El-Laboudi et al.   Diabetes Technology & Therapeutics

Q-Score: development of a new metric for continuous glucose monitoring that enables stratification of antihyperglycaemic therapies

(2015) Petra Augstein et al.   BMC Endocrine Disorders

Association of time in blood glucose range with outcomes following cardiac surgery

(2015) Amr S Omar et al.   BMC Anesthesiology

Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes

(2014) Steven J. Russell et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview

(2013) David M. Nathan et al.   DIABETES CARE

Effect of Short-Term iPRO Continuous Glucose Monitoring on Hemoglobin A1c Levels in Clinical Practice

(2012) Gary M. Pepper et al.   Diabetes Technology & Therapeutics

Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 Diabetes

(2011) R. A. Vigersky et al.   DIABETES CARE

Real-time continuous glucose monitoring system for treatment of diabetes: a systematic review

(2010) L. B. E. A. Hoeks et al.   DIABETIC MEDICINE

Translating the A1C Assay Into Estimated Average Glucose Values

(2008) D. M. Nathan et al.   DIABETES CARE